Pluribus Labs’s Crown Castle CCI Stock Holding History

Pluribus Labs’s Portfolio CCI Stock Details CCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,682	Closed	-$351K	–	82
2021 Q4	$351K	Buy	+1,682	New	+$311K	0.37%	105

Other funds holding CCI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pluribus Labs's CCI Position: Q1 2022 in Review

Pluribus Labs sold out of Crown Castle (CCI) in Q1 2022, closing a stake of 1,682 shares — an estimated $351K sold.

Pluribus Labs first reported a position in CCI in Q4 2021 and held it in 1 quarter. The position peaked at $351K in Q4 2021. 1,344 funds tracked by Wall St. Rank hold CCI as of Q1 2022.

Pluribus Labs reported no remaining Crown Castle position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 1,682 Crown Castle shares in Q1 2022, an estimated $351K.
Pluribus Labs first reported a position in Crown Castle in Q4 2021 and held it in 1 quarter.
Pluribus Labs's Crown Castle position peaked at $351K in Q4 2021.
1,344 funds tracked by Wall St. Rank held Crown Castle as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.